InSysBio Announces Collaboration on Quantitative System Pharmacology Modeling of Chronic Obstructive Pulmonary Disease

NEWS
Press-Release
June 13, 2018

June 13, 2018

InSysBio LLC (www.insysbio.com), a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, announced today a collaboration with GSK, one of the world’s leading research-based pharmaceutical and healthcare companies, for development of QSP platform of Chronic Obstructive Pulmonary Disease (COPD).

The aim of collaboration is to develop a comprehensive QSP platform of COPD and its treatment including detailed description of immune cell dynamics, effect of cigarette smoke, extracellular matrix remodeling and other aspects of disease progression.

About InSysBio

InSysBio (formerly Institute for System Biology Moscow) was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of quantitative systems pharmacology (QSP) modeling. InSysBio’s innovative approach has already become a part of the drug development process implemented by our strategic partners: nowadays there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. The company has published a lot of scientific studies in various therapeutic areas. InSysBio team is developing software and tools for QSP and continuously improves methods for biological modeling. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

October 2022
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
1. 12 Oct 2022 16:07 InSysBio to take part in ACoP13 InSysBio announces its participation in the Thirteenth American Conference on Pharmacometrics (ACoP13) which is to be held in person from October 30th to November 2nd, 2022, at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado. InSysBio team is going to present 7 posters in frames of the Conference
13
14
15
16
17
18
19
20
21
22
23
24
25
1. 25 Oct 2022 14:41 InSysBio to present its ePoster at ECTRIMS 2022 InSysBio team is going to present its poster in frames of 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis which is to be held October 26-28, Amsterdam, the Netherlands. The ePoster is going to be presented in frames of "Pathology and pathogenesis of MS - Neurodegeneration" ePoster Area, October 26
26
27
28
29
30
31
      
Upcoming Events
Tags
Latest News
09.11
InSysBio to start the operation of new Headquarters and new branch office
11.07
InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics
24.05
InSysBio to establish a new legal entity in Cyprus
25.04
InSysBio's ASCPT 2022 Micro-Theater Session on YouTube
20.01
InSysBio to release Immune Response Template v. 3.6.0